NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

Conditions:   Coronary Artery Disease;   Percutaneous Coronary Intervention;   Acute Coronary Syndrome Interventions:   Drug: Aspirin + Clopidogrel + Rivaroxaban;   Drug: Aspirin + Clopidogrel Sponsor:   China National Center for Cardiovascular Diseases Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials